News Announcement

Supriya Lifescience: Unaudited Financial Results For The Quarter Ended June 30 2022

Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please be informed that the Board of Directors of the Company at its Meeting held on Friday August 12 2022 inter-alia has:1. Considered and approved the Unaudited Financial Results for the Quarter ended June 30 2022.2. Recommended re-appointment of M/s. Kakaria & Associates LLP Chartered Accountants (Firm Registration No. 104558W/W100601) as the Statutory Auditors of the Company for second term of five years from the conclusion of the ensuing 14th AGM till the conclusion of the 19th AGM to be held in the year 2027 subject to approval of the members at the ensuing 14th AGM..

वैल्यू रिसर्च से पूछें aks value research information

कोई सवाल छोटा नहीं होता. पर्सनल फ़ाइनांस, म्यूचुअल फ़ंड्स, या फिर स्टॉक्स पर बेझिझक अपने सवाल पूछिए, और हम आसान भाषा में आपको जवाब देंगे.